Literature DB >> 24149440

The TOMM machinery is a molecular switch in PINK1 and PARK2/PARKIN-dependent mitochondrial clearance.

Giulia Bertolin1, Rosa Ferrando-Miguel, Maxime Jacoupy, Sabine Traver, Karl Grenier, Andrew W Greene, Aurélien Dauphin, François Waharte, Aurélien Bayot, Jean Salamero, Anne Lombès, Anne-Laure Bulteau, Edward A Fon, Alexis Brice, Olga Corti.   

Abstract

Loss-of-function mutations in PARK2/PARKIN and PINK1 cause early-onset autosomal recessive Parkinson disease (PD). The cytosolic E3 ubiquitin-protein ligase PARK2 cooperates with the mitochondrial kinase PINK1 to maintain mitochondrial quality. A loss of mitochondrial transmembrane potential (ΔΨ) leads to the PINK1-dependent recruitment of PARK2 to the outer mitochondrial membrane (OMM), followed by the ubiquitination and proteasome-dependent degradation of OMM proteins, and by the autophagy-dependent clearance of mitochondrial remnants. We showed here that blockade of mitochondrial protein import triggers the recruitment of PARK2, by PINK1, to the TOMM machinery. PD-causing PARK2 mutations weakened or disrupted the molecular interaction between PARK2 and specific TOMM subunits: the surface receptor, TOMM70A, and the channel protein, TOMM40. The downregulation of TOMM40 or its associated core subunit, TOMM22, was sufficient to trigger OMM protein clearance in the absence of PINK1 or PARK2. However, PARK2 was required to promote the degradation of whole organelles by autophagy. Furthermore, the overproduction of TOMM22 or TOMM40 reversed mitochondrial clearance promoted by PINK1 and PARK2 after ΔΨ loss. These results indicated that the TOMM machinery is a key molecular switch in the mitochondrial clearance program controlled by the PINK1-PARK2 pathway. Loss of functional coupling between mitochondrial protein import and the neuroprotective degradation of dysfunctional mitochondria may therefore be a primary pathogenic mechanism in autosomal recessive PD.

Entities:  

Keywords:  PARK2; PINK1; Parkinson disease; TOMM machinery; mitochondria; mitophagy; outer mitochondrial membrane

Mesh:

Substances:

Year:  2013        PMID: 24149440     DOI: 10.4161/auto.25884

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  46 in total

Review 1.  How mitochondrial dynamism orchestrates mitophagy.

Authors:  Orian S Shirihai; Moshi Song; Gerald W Dorn
Journal:  Circ Res       Date:  2015-05-22       Impact factor: 17.367

2.  The Broad Impact of TOM40 on Neurodegenerative Diseases in Aging.

Authors:  William K Gottschalk; Michael W Lutz; Yu Ting He; Ann M Saunders; Daniel K Burns; Allen D Roses; Ornit Chiba-Falek
Journal:  J Parkinsons Dis Alzheimers Dis       Date:  2014-11

Review 3.  Mitochondrial proteostasis in the context of cellular and organismal health and aging.

Authors:  Erica A Moehle; Koning Shen; Andrew Dillin
Journal:  J Biol Chem       Date:  2018-04-05       Impact factor: 5.157

Review 4.  Proteoglycan-driven Autophagy: A Nutrient-independent Mechanism to Control Intracellular Catabolism.

Authors:  Thomas Neill; Simone Buraschi; Aastha Kapoor; Renato V Iozzo
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

5.  Parkin maintains mitochondrial levels of the protective Parkinson's disease-related enzyme 17-β hydroxysteroid dehydrogenase type 10.

Authors:  G Bertolin; M Jacoupy; S Traver; R Ferrando-Miguel; T Saint Georges; K Grenier; H Ardila-Osorio; M-P Muriel; H Takahashi; A J Lees; C Gautier; D Guedin; F Coge; E A Fon; A Brice; O Corti
Journal:  Cell Death Differ       Date:  2015-01-16       Impact factor: 15.828

6.  Aurora kinase A localises to mitochondria to control organelle dynamics and energy production.

Authors:  Giulia Bertolin; Anne-Laure Bulteau; Marie-Clotilde Alves-Guerra; Agnes Burel; Marie-Thérèse Lavault; Olivia Gavard; Stephanie Le Bras; Jean-Philippe Gagné; Guy G Poirier; Roland Le Borgne; Claude Prigent; Marc Tramier
Journal:  Elife       Date:  2018-08-02       Impact factor: 8.140

Review 7.  Defective autophagy in Parkinson's disease: lessons from genetics.

Authors:  H Zhang; C Duan; H Yang
Journal:  Mol Neurobiol       Date:  2014-07-04       Impact factor: 5.590

8.  Impact of C24:0 on actin-microtubule interaction in human neuronal SK-N-BE cells: evaluation by FRET confocal spectral imaging microscopy after dual staining with rhodamine-phalloidin and tubulin tracker green.

Authors:  Amira Zarrouk; Thomas Nury; Aurélien Dauphin; Perrine Frère; Jean-Marc Riedinger; Claude-Marie Bachelet; Frédérique Frouin; Thibault Moreau; Mohamed Hammami; Edmond Kahn; Gérard Lizard
Journal:  Funct Neurol       Date:  2015 Jan-Mar

9.  α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson's disease.

Authors:  Roberto Di Maio; Paul J Barrett; Eric K Hoffman; Caitlyn W Barrett; Alevtina Zharikov; Anupom Borah; Xiaoping Hu; Jennifer McCoy; Charleen T Chu; Edward A Burton; Teresa G Hastings; J Timothy Greenamyre
Journal:  Sci Transl Med       Date:  2016-06-08       Impact factor: 17.956

Review 10.  Aberrant autophagy and parkinsonism: does correction rescue from disease progression?

Authors:  Abhishek Kumar Mishra; Mohd Sami ur Rasheed; Saurabh Shukla; Manish Kumar Tripathi; Anubhuti Dixit; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2014-05-16       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.